Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$266K Sell
787
-17,362
-96% -$5.64M 0.1% 162
2018
Q2
$5.4M Sell
18,149
-7,176
-28% -$2.1M 0.84% 15
2018
Q1
$6.81M Sell
25,325
-9,282
-27% -$2.51M 0.73% 27
2017
Q4
$8.59M Sell
34,607
-16,174
-32% -$3.99M 0.75% 17
2017
Q3
$12.4M Buy
50,781
+29,087
+134% +$7.13M 1.36% 5
2017
Q2
$5.22M Sell
21,694
-117
-0.5% -$26.5K 0.53% 31
2017
Q1
$4.5M Buy
+21,811
New +$4.51M 0.26% 98
2015
Q3
Sell
-18,756
Closed -$3.59M 754
2015
Q2
$3.59M Buy
+18,756
New +$3.48M 0.5% 37
2014
Q3
Sell
-2,199
Closed -$281K 425
2014
Q2
$281K Sell
2,199
-13
-0.6% -$1.54K 0.14% 249
2014
Q1
$249K Sell
2,212
-2,882
-57% -$300K 0.09% 293
2013
Q4
$526K Buy
+5,094
New +$499K 0.17% 159

Other funds holding HUM

Clinton Group's HUM Position: Q3 2018 in Review

Clinton Group reduced its Humana (HUM) stake by 96% in Q3 2018, selling an estimated $5.64M and leaving 787 shares worth $266K. The position accounts for 0.1% of the portfolio, ranked #162.

Clinton Group first reported a position in HUM in Q4 2013 and has held it in 11 quarters since. The position peaked at $12.4M in Q3 2017. 730 funds tracked by Wall St. Rank hold HUM as of Q3 2018.

  • Clinton Group held 787 shares of Humana worth $266K as of Q3 2018.
  • Clinton Group sold 17,362 Humana shares in Q3 2018, an estimated $5.64M.
  • Humana made up 0.1% of Clinton Group's portfolio in Q3 2018, its #162 holding.
  • Clinton Group first reported a position in Humana in Q4 2013 and has held it in 11 quarters since.
  • Clinton Group's Humana position peaked at $12.4M in Q3 2017.
  • 730 funds tracked by Wall St. Rank held Humana as of Q3 2018.

Based on Clinton Group's 13F filing for Q3 2018, filed 10 Oct 2018.